Study of an experimental drug for women with orgasm difficulty
Part of Mental health clinical trials.
This study tests an experimental medication (S1B-408) to see if it helps women who have trouble reaching orgasm. The trial will check if the drug improves orgasm function compared to a placebo, and you will need to have a willing partner and be sexually active.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 60 years old.
- You are in a sexual relationship and have been sexually active in the past month.
- Your main sexual problem is difficulty reaching orgasm, which started recently (not lifelong) and happens in most situations.
- Your depression or anxiety (if any) is mild and controlled with the same treatment throughout the study.
- You are not pregnant, not breastfeeding, and agree to use reliable birth control.
- You and your partner agree to have sex at least once a week during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication (BZ371A) that may help women with sexual arousal disorder—a condition where the body doesn't respond physically (like lubrication or swelling) despite feeling interested. The trial aims to see if this medication can increase sexual arousal, and checks safety and side effects over a period of time with your partner.
This trial tests an investigational medication, BZ371A, to see if it can help women with Female Sexual Arousal Disorder (FSAD), a condition where they have trouble getting or keeping physical signs of arousal like lubrication and warmth. The study aims to find out if BZ371A is safe, effective, and well-tolerated.
This study tests two devices (BTL-699-2 and HPM-6000UF) to see if they can improve depression symptoms and sexual function in women going through menopause or perimenopause. It may help with mood and intimacy during this life stage.
This study tests a device that uses gentle electrical stimulation to improve sexual function in women. You can use it at home after being trained at the study center.
This study tests an experimental medicine for premenstrual dysphoric disorder (PMDD), a severe form of PMS. It is a phase 1 trial, so the main goal is to check the drug's safety and how your body handles it, but it may also help assess its effectiveness.
This study tests a new medicine, W2505, to see if it is safe and effective for men with erectile dysfunction. Participation may help you manage your condition and contribute to research.
Hear when a new Orgasmic Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.